KHLMVGHM
BIIB icon

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Biogen BIIB Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-54,585
Closed -$8.34M – 65
2024
Q4 		$8.34M Buy
+54,585
New +$9.21M 0.66% 47

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's BIIB Position: Q1 2025 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of Biogen (BIIB) in Q1 2025, closing a stake of 54,585 shares — an estimated $8.34M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in BIIB in Q4 2024 and held it in 1 quarter. The position peaked at $8.34M in Q4 2024. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 54,585 Biogen shares in Q1 2025, an estimated $8.34M.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Biogen in Q4 2024 and held it in 1 quarter.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's Biogen position peaked at $8.34M in Q4 2024.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q1 2025, filed 7 May 2025.